MAML2
Mastermind-like protein 2
Also known as: KIAA1819, MAM3, MAML2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZL2
- Gene
- MAML2
- Ensembl
- ENSG00000184384
- Chromosome
- 11
- Canonical length
- 1156 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the Mastermind-like family of proteins. All family members are proline and glutamine-rich, and contain a conserved basic domain that binds the ankyrin repeat domain of the intracellular domain of the Notch receptors (ICN1-4) in their N-terminus, and a transcriptional activation domain in their C-terminus. This protein binds to an extended groove that is formed by the interaction of CBF1, Suppressor of Hairless, LAG-1 (CSL) with ICN, and positively regulates Notch signaling. High levels of expression of this gene have been observed in several B cell-derived lymphomas. Translocations resulting in fusion proteins with both CRTC1 and CRTC3 have been implicated in the development of mucoepidermoid carcinomas, while a translocation event with CXCR4 has been linked with chronic lymphocytic leukemia (CLL). Copy number variation in the polyglutamine tract has been observed. [provided by RefSeq, Jan 2015]
Canonical amino-acid sequenceUniProt
1156 residues, UniProt reviewed canonical sequence.
>Q8IZL2|MAML2
1 MGDTAPPQAP AGGLGGASGA GLLGGGSVTP RVHSAIVERL RARIAVCRQH HLSCEGRYER
61 GRAESSDRER ESTLQLLSLV QHGQGARKAG KHTKATATAA TTTAPPPPPA APPAASQAAA
121 TAAPPPPPDY HHHHQQHLLN SSNNGGSGGI NGEQQPPAST PGDQRNSALI ALQGSLKRKQ
181 VVNLSPANSK RPNGFVDNSF LDIKRIRVGE NLSAGQGGLQ INNGQSQIMS GTLPMSQAPL
241 RKTNTLPSHT HSPGNGLFNM GLKEVKKEPG ETLSCSKHMD GQMTQENIFP NRYGDDPGEQ
301 LMDPELQELF NELTNISVPP MSDLELENMI NATIKQDDPF NIDLGQQSQR STPRPSLPME
361 KIVIKSEYSP GLTQGPSGSP QLRPPSAGPA FSMANSALST SSPIPSVPQS QAQPQTGSGA
421 SRALPSWQEV SHAQQLKQIA ANRQQHARMQ QHQQQHQPTN WSALPSSAGP SPGPFGQEKI
481 PSPSFGQQTF SPQSSPMPGV AGGSGQSKVM ANYMYKAGPS AQGGHLDVLM QQKPQDLSRS
541 FINNPHPAME PRQGNTKPLF HFNSDQANQQ MPSVLPSQNK PSLLHYTQQQ QQQQQQQQQQ
601 QQQQQQQQQQ QQQQQQQQQQ QSSISAQQQQ QQQSSISAQQ QQQQQQQQQQ QQQQQQQQQQ
661 QQQQQPSSQP AQSLPSQPLL RSPLPLQQKL LLQQMQNQPI AGMGYQVSQQ QRQDQHSVVG
721 QNTGPSPSPN PCSNPNTGSG YMNSQQSLLN QQLMGKKQTL QRQIMEQKQQ LLLQQQMLAD
781 AEKIAPQDQI NRHLSRPPPD YKDQRRNVGN MQPTAQYSGG SSTISLNSNQ ALANPVSTHT
841 ILTPNSSLLS TSHGTRMPSL STAVQNMGMY GNLPCNQPNT YSVTSGMNQL TQQRNPKQLL
901 ANQNNPMMPR PPTLGPSNNN NVATFGAGSV GNSQQLRPNL THSMASMPPQ RTSNVMITSN
961 TTAPNWASQE GTSKQQEALT SAGVRFPTGT PAAYTPNQSL QQAVGSQQFS QRAVAPPNQL
1021 TPAVQMRPMN QMSQTLNGQT MGPLRGLNLR PNQLSTQILP NLNQSGTGLN QSRTGINQPP
1081 SLTPSNFPSP NQSSRAFQGT DHSSDLAFDF LSQQNDNMGP ALNSDADFID SLLKTEPGND
1141 DWMKDINLDE ILGNNSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAML2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- breast: 13 nTPM
- thymus: 13 nTPM
- placenta: 12 nTPM
- salivary gland: 10 nTPM
- adipose tissue: 10 nTPM
- cervix: 10 nTPM
Single-cell type
- distal convoluted tubule cells: 2,700 nCPM
- cone photoreceptor cells: 1,954 nCPM
- bergmann glia: 1,791 nCPM
- microglia: 1,741 nCPM
- oligodendrocyte progenitor cells: 1,712 nCPM
- neutrophils: 1,415 nCPM
Immune cell
- naive CD4 T-cell: 3.2 nTPM
- neutrophil: 2.6 nTPM
- NK-cell: 2.4 nTPM
- naive CD8 T-cell: 2.2 nTPM
- memory CD8 T-cell: 2.1 nTPM
- memory CD4 T-cell: 1.6 nTPM
Brain region
- cerebellum: 43 nTPM
- hypothalamus: 30 nTPM
- medulla oblongata: 27 nTPM
- midbrain: 27 nTPM
- spinal cord: 22 nTPM
- hippocampal formation: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- Notch signaling pathway
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription of Notch receptor target
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Neurogenic mastermind-like, N-terminal
- Mastermind-like 1-3
- Neurogenic mastermind-like, N-terminal domain superfamily
- MamL-1 domain
- Mastermind-like protein 2, transcriptional activation domain
- Mastermind-like protein 2, transcriptional activation domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAML2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAML2 as an antibody target. Whether an autoantibody or antibody against MAML2 could matter depends on whether native MAML2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAML2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAML2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...